ecancermedicalscience editor's choice for July and August 2014

Networking and collaborating across borders in sub-Saharan Africa

Molecular investigations of immune cells and tumour environment: The ovarian cancer model

HPV-targeted adoptive T Cell therapy for advanced cervical cancer

HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer

Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

ASCO 2014 roundup

Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers

Targeted drug combo, cediranib plus olaparib, significantly increases progression-free survival in recurrent ovarian cancer

Cediranib plus olaparib significantly increases PFS in recurrent ovarian cancer

Role of AORTIC in dealing with rising cancer rates in Africa

Role of genomics in assessing risk, especially in ovarian cancer